| 000 | 01791 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515183800.0 | ||
| 264 | 0 | _c20100917 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1524-4733 | ||
| 024 | 7 |
_a10.1111/j.1524-4733.2009.00577.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMueller, Dirk | |
| 245 | 0 | 0 |
_aCost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women. _h[electronic resource] |
| 260 |
_bValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research _c |
||
| 300 |
_a1106-17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAbsorptiometry, Photon _xeconomics |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlendronate _xeconomics |
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xeconomics |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFractures, Bone _xeconomics |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMarkov Chains |
| 650 | 0 | 4 |
_aMass Screening _xeconomics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xcomplications |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aQuality-Adjusted Life Years |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aWomen's Health |
| 700 | 1 | _aGandjour, Afschin | |
| 773 | 0 |
_tValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research _gvol. 12 _gno. 8 _gp. 1106-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1524-4733.2009.00577.x _zAvailable from publisher's website |
| 999 |
_c19107916 _d19107916 |
||